nad has been researched along with Lung Neoplasms in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (11.43) | 18.7374 |
1990's | 5 (14.29) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 10 (28.57) | 24.3611 |
2020's | 12 (34.29) | 2.80 |
Authors | Studies |
---|---|
Li, R; Lish, SR; Xie, X; Xu, M; Xu, Z; Yu, K | 1 |
He, P; Hou, Y; Li, N; Liu, Z; Yang, Y; Zhang, X | 1 |
Boldrini, L; Bria, E; Chiappetta, M; Ciavarella, LP; Congedo, MT; Evangelista, J; Larici, A; Lococo, F; Margaritora, S; Nachira, D; Porziella, V; Sassorossi, C | 1 |
Boldrini, L; Bria, E; Cesario, A; Charles-Davies, D; Chiappetta, M; Congedo, MT; Evangelista, J; Lococo, F; Margaritora, S; Massaccesi, M; Nachira, D; Porziella, V; Sassorossi, C; Sperduti, I; Valentini, V; Vita, E | 1 |
Chen, P; Huang, P; Jiang, K; Jiang, S; Lin, J; Zhang, X; Zhao, F | 1 |
Chen, L; Chen, S; Chen, W; Fu, W; Jiang, S; Jiang, Z; Li, D; Li, X; Ma, X; Pan, Y; Wang, Q; Xing, X; Xu, C; Zhang, L; Zhou, H | 1 |
Arslan, AA; Behndig, AF; Brennan, P; Cai, Q; Chen, C; Chen, Y; Fanidi, A; Freedman, ND; Gaziano, JM; Giles, GG; Huang, WY; Johansson, M; Koh, WP; Langhammer, A; Le Marchand, L; Manjer, J; Meyer, K; Midttun, Ø; Prentice, R; Robbins, HA; Sandsveden, M; Sesso, HD; Shu, XO; Stevens, VL; Sørgjerd, EP; Ueland, PM; Ulvik, A; Visvanathan, K; Wang, Y; Weinstein, SJ; Yuan, JM; Zahed, H; Zhang, X; Zheng, W | 1 |
Adelmann, CH; Bar-Peled, L; Bardeesy, N; Carlin, A; de Groot, A; Dürr, BR; Fischer, H; Fisher, DE; Ge, M; Gohar, M; Haigis, MC; Harry, S; Hata, AN; Hayashi, M; Mostoslavsky, R; Papagiannakopoulos, T; Richter, M; Shi, L; Takahashi, M; Vijay, V; Vornbäumen, T; Wei, TY; Weiss-Sadan, T; Wolf, K; Yang, TY; Yao, CH; Zhang, J | 1 |
Bey, EA; Boatman, MA; Carter, JH; Madajewski, B; Martinez, I | 1 |
Ai, N; Chen, X; Ge, W; Hou, Y; Lu, JJ; Yu, J; Zhao, L; Zhong, B | 1 |
Chen, T; Deng, Y; Fan, Q; Gao, J; Li, M; Li, X; Li, Z; Liu, G; Sun, L; Yao, F; Zeng, Z; Zhang, Z; Zhong, C | 1 |
Krawic, C; Luczak, MW; Zhitkovich, A | 1 |
Chen, S; Feun, LG; Kandemir, H; Kuo, MT; Li, YY; Nguyen, DJM; Prince, JS; Savaraj, N; Shah, S; Wangpaichitr, M; Wu, C | 1 |
Shao, B; Tian, L; Yan, Y; Zhou, W; Zhu, B | 1 |
Adam, J; Ashworth, A; Bigot, L; Bouillaud, F; Chabanon, RM; Dorvault, N; Durand, S; Frankum, JR; Friboulet, L; Garrido, M; Krastev, DB; Kuo, MS; Lombès, A; Lord, CJ; Mardakheh, F; Morel, D; Olaussen, KA; Pierron, G; Pontoizeau, C; Postel-Vinay, S; Sarasin, A; Sauvaigo, S; Soria, JC; Souquère, S; Sourisseau, T; Touat, M | 1 |
Felding-Habermann, B; Gay, LJ; LeBoeuf, SE; Matsuno-Yagi, A; Ritland, M; Santidrian, AF; Seo, BB; Yagi, T | 1 |
Belmont, LD; DelNagro, C; Durieux, JK; Elkins, K; Jackson, PK; Kwong, M; Lee, L; Liang, X; Liederer, BM; O'Brien, T; Oeh, J; Sampath, D; Tremayne, J; Xiao, Y; Yang, LX | 1 |
Chen, L; Ma, J; Qu, C; Sun, F; Wu, J; Xu, H; Xu, S; Zheng, D | 1 |
Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, JS; Lee, SH; Nam, B; Seong, TW; Son, J | 1 |
Cheng, X; Hao, H; Li, Q; Liu, F; Liu, H; Wang, G; Wang, H; Xing, R; Ye, H; Zhao, M | 1 |
Ahn, HS; Ahn, JH; Hong, D; Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, CH; Lee, JH; Lee, JS; Lee, SH; Seong, TW | 1 |
Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
Beauparlant, P; Bédard, D; Bernier, C; Chan, H; Gilbert, K; Goulet, D; Gratton, MO; Lavoie, M; Roulston, A; Turcotte, E; Watson, M | 1 |
Chen, YW; Grossman, SR; Kovi, RC; Lewis, BC; Nath, B; Paliwal, S | 1 |
Björkling, F; Christensen, MK; Jäättelä, M; Jensen, PB; Nielsen, SJ; Olesen, UH; Sehested, M | 1 |
Ichikawa, T; Ishikawa, G; Yano, T | 1 |
Beall, HD; Gibson, NW; Mulcahy, RT; Ross, D; Siegel, D; Traver, RD | 1 |
Ewing, JF; Janero, DR | 1 |
Martin-Mateo, MC; Molpeceres, LM; Ramos, G | 1 |
Huang, AC; Jacobson, EL; Shieh, WM | 1 |
Begleiter, A; Fiterman, DJ; Fourie, J; Guziec, F; Guziec, L; Monterrosa, C; Oleschuk, CJ | 1 |
Comes, R; Mustea, I | 1 |
Díaz Pérez, A; González Azpeitia, J; Nuño Lopez, J; Pereda, JM; Romero López, J; Sanchidrian, P | 1 |
Biaglow, JE; Tuttle, SW; Varnes, ME | 1 |
Kurshakova, NN | 1 |
35 other study(ies) available for nad and Lung Neoplasms
Article | Year |
---|---|
Information entropy of quantitative chemometric endogenous fluorescence improves photonic lung cancer diagnosis.
Topics: Chemometrics; Entropy; Flavin-Adenine Dinucleotide; Fluorescence; Humans; Lung; Lung Neoplasms; NAD | 2022 |
Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutamine; Humans; Ketones; Lung Neoplasms; Mice; Mitochondria; NAD | 2022 |
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; NAD; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 2022 |
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Retrospective Studies | 2022 |
In Vivo Near-Infrared Fluorescence/Ratiometric Photoacoustic Duplex Imaging of Lung Cancer-Specific hNQO1.
Topics: Fluorescence; Fluorescent Dyes; Humans; Lung Neoplasms; NAD; Quinones | 2022 |
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; DNA; DNA Methylation; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NADP Transhydrogenases; Sirtuin 1 | 2023 |
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium.
Topics: Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Humans; Inflammation; Interferon-gamma; Kynurenine; Lung Neoplasms; NAD; Neopterin; Tryptophan | 2023 |
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NAD; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2023 |
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); NADH, NADPH Oxidoreductases; Quinones | 2023 |
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Ferroptosis; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Reactive Oxygen Species; RNA, Small Interfering; Zebrafish | 2023 |
Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; Lung Neoplasms; Lymphatic Metastasis; NAD; Signal Transduction | 2023 |
NAD
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Amino Acids, Dicarboxylic; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Hypoxia; Cell Proliferation; Cytokines; Fibroblasts; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Lung Neoplasms; NAD; Nicotinamide Phosphoribosyltransferase; Signal Transduction; Transfection | 2021 |
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression; Glucose; Glutamic Acid; Glutamine; Glycolysis; Heterografts; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Mice; Mitochondria; Models, Biological; NAD; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Riluzole | 2017 |
Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
Topics: Aged; Asian People; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Down-Regulation; Ethnicity; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lysine; Male; Middle Aged; NAD; Neoplasm Metastasis; Prognosis; RNA, Messenger; Sirtuins; Survival Analysis | 2018 |
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cytokines; DNA Repair; DNA-Binding Proteins; Endonucleases; Humans; Lung Neoplasms; Mice; Mice, Nude; NAD; Neoplasm Proteins; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase | 2018 |
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.
Topics: Acrylamides; Animals; Autophagy; Autophagy-Related Protein 5; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Progression; Electron Transport Complex I; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; Mice, SCID; Microtubule-Associated Proteins; Mitochondria; Multiprotein Complexes; NAD; Neoplasm Transplantation; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; Protein Transport; Proteins; Recombinant Proteins; Saccharomyces cerevisiae Proteins; TOR Serine-Threonine Kinases | 2013 |
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Heterografts; Humans; Lung Neoplasms; Mice, Nude; NAD; Pentosyltransferases; Pyrazoles; Sulfones | 2013 |
Gene expression profiling analysis of lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Down-Regulation; Female; Gene Expression Profiling; Gene Regulatory Networks; Humans; Lung Neoplasms; Male; Microfilament Proteins; Middle Aged; Mitogen-Activated Protein Kinase 1; NAD; Protein Interaction Maps; Proto-Oncogene Proteins c-raf; Up-Regulation | 2016 |
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Topics: Action Potentials; Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosol; Female; Gossypol; Humans; Lung Neoplasms; Malates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NAD; NADP; Neoplasm Transplantation; Oxidative Phosphorylation; Oxidoreductases Acting on CH-NH Group Donors; Phenformin; RNA, Small Interfering | 2016 |
De-novo NAD+ synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells.
Topics: A549 Cells; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Mice; Mice, Nude; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasm Transplantation; Oxidative Stress; Oxygen; Signal Transduction; Sirtuin 1; Tryptophan | 2016 |
Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
Topics: Adenosine Triphosphate; Aldehyde Dehydrogenase; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; NAD; Protein Isoforms | 2016 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Line, Tumor; Colonic Neoplasms; Cyanides; Cytokines; Drug Screening Assays, Antitumor; Female; Guanidines; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Multiple Myeloma; NAD; Neoplasm Proteins; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Prodrugs; Xenograft Model Antitumor Assays | 2009 |
The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
Topics: Alcohol Oxidoreductases; Cell Hypoxia; Cell Movement; Co-Repressor Proteins; Eye Proteins; Genes, Tumor Suppressor; HCT116 Cells; Humans; Lung Neoplasms; NAD; Nerve Tissue Proteins; Oxygen; Phosphatidylinositol 3-Kinases; Reading Frames; Transfection | 2007 |
Anticancer agent CHS-828 inhibits cellular synthesis of NAD.
Topics: Acrylamides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyanides; Dose-Response Relationship, Drug; Guanidines; Humans; Lung Neoplasms; NAD; Piperidines; Signal Transduction | 2008 |
Oxidative stress as a modulating factor of pulmonary tumorigenesis in mice; comparative study on two different strains.
Topics: 4-Nitroquinoline-1-oxide; Animals; Cell Nucleus; Glycerol; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred A; Microsomes; NAD; NADP; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances | 1993 |
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
Topics: Aerobiosis; Animals; Antineoplastic Agents; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Chromatography, High Pressure Liquid; DNA Damage; DNA, Neoplasm; Escherichia coli; Humans; Kinetics; Lung Neoplasms; Mitomycin; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Transfection; Tumor Cells, Cultured | 1994 |
Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator.
Topics: Animals; Bacterial Proteins; Carcinoma; Cattle; Colorimetry; Enzyme Inhibitors; Humans; Isoenzymes; Lung Neoplasms; Male; Methylphenazonium Methosulfate; Microchemistry; NAD; Neoplasm Proteins; Nitroblue Tetrazolium; Organ Specificity; Oxidation-Reduction; Potassium Cyanide; Rats; Rats, Sprague-Dawley; Spectrophotometry; Superoxide Dismutase; Superoxides; Tumor Cells, Cultured | 1995 |
Assay for erythrocyte superoxide dismutase activity in patients with lung cancer and effects on pollution and smoke trace elements.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Environmental Pollutants; Erythrocytes; Female; Free Radicals; Humans; Lung Neoplasms; Male; Middle Aged; NAD; Neoplasm Staging; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Tobacco Smoke Pollution; Trace Elements | 1997 |
Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis.
Topics: Animals; Breast Neoplasms; Humans; Lung Neoplasms; NAD; Neoplasms; Niacin; Rats; Skin; Skin Neoplasms; Species Specificity; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Topics: Antineoplastic Agents; Benzoquinones; Biotransformation; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
The levels of NAD and NADH in blood of patients with cancer.
Topics: Breast Neoplasms; Female; Glucose; Humans; Lung Neoplasms; NAD; Neoplasm Metastasis; Neoplasms; Uterine Cervical Neoplasms | 1976 |
[Study of sputum by using the SMA 12/60. Preliminary observations].
Topics: Autoanalysis; Humans; L-Lactate Dehydrogenase; Lung Diseases; Lung Neoplasms; NAD; Sputum | 1977 |
Role of cellular non-protein thiols in oxygen consumption and peroxide reduction.
Topics: Cell Line; Ethylmaleimide; Humans; Kinetics; Lung Neoplasms; NAD; Oxidation-Reduction; Oxygen Consumption; Peroxides; Sulfhydryl Compounds | 1986 |
[On changes in oxido-reductive enzymes in the course of the development of lung cancer induced by radioactive cerium].
Topics: Animals; Bronchial Neoplasms; Cerium Isotopes; Chinchilla; Dihydrolipoamide Dehydrogenase; Electron Transport Complex IV; Lung Neoplasms; NAD; NADP; Neoplasms, Radiation-Induced; Oxidoreductases; Rabbits; Radioisotopes; Succinate Dehydrogenase | 1967 |